PAS
ATOS icon

Point72 Asia (Singapore)’s Atossa Therapeutics ATOS Stock Holding History

Point72 Asia (Singapore)’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$38.2K Sell
2,940
-2,941
-50% -$36.3K 0.01% 610
2025
Q2 		$73.2K Buy
+5,881
New +$70.3K 0.01% 528
2024
Q2 		– Sell
-9,391
Closed -$254K – 1054
2024
Q1 		$254K Buy
+9,391
New +$151K 0.07% 338

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Point72 Asia (Singapore)'s ATOS Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its Atossa Therapeutics (ATOS) stake by 50% in Q3 2025, selling an estimated $36.3K and leaving 2,940 shares worth $38.2K. The position accounts for 0.01% of the portfolio, ranked #610.

Point72 Asia (Singapore) first reported a position in ATOS in Q1 2024 and has held it in 3 quarters since. The position peaked at $254K in Q1 2024. 66 funds tracked by Wall St. Rank hold ATOS as of Q3 2025.

  • Point72 Asia (Singapore) held 2,940 shares of Atossa Therapeutics worth $38.2K as of Q3 2025.
  • Point72 Asia (Singapore) sold 2,941 Atossa Therapeutics shares in Q3 2025, an estimated $36.3K.
  • Atossa Therapeutics made up 0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #610 holding.
  • Point72 Asia (Singapore) first reported a position in Atossa Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • Point72 Asia (Singapore)'s Atossa Therapeutics position peaked at $254K in Q1 2024.
  • 66 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.